Recently, it has been shown that LSD1 inhibition in triple negative breast cancer cell lines induces expression of CD8+ T cell-attracting chemokines, including CCL5, CXCL9, and CXCL10 [61]. The gene discussed is CXCL10; the disease is triple-negative breast carcinoma.